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Abstract: 
 
Background: Monitoring cerebrovascular reactivity in adult traumatic brain injury (TBI) has been linked 
to global patient outcome.  Three intra-cranial pressure (ICP) derived indices have been described.  It is 
unknown which index is superior for outcome association in TBI outside previous single-center 
evaluations.  The goal of this study is to evaluate indices for 6 to 12-month outcome association using 
uniform data harvested in multiple centers.  
Methods: Using the prospectively collected data from the Collaborative European NeuroTrauma 
Effectiveness Research in TBI (CENTER-TBI) study, the following indices of cerebrovascular reactivity 
were derived: PRx (correlation between ICP and mean arterial pressure (MAP)), PAx (correlation 
between pulse amplitude of ICP (AMP) and MAP), and RAC (correlation between AMP and cerebral 
perfusion pressure (CPP)).  Univariate logistic regression models were created to assess the association 
between vascular reactivity indices with global dichotomized outcome at 6 to 12 months, as assessed by 
Glasgow Outcome Score – Extended (GOSE).  Models were compared via area under the receiver 
operating curve (AUC) and Delong’s Test. 
Results: Two separate patient groups from this cohort were assessed:  the total population with 
available data (n=204), and only those without decompressive craniectomy (n=159), with identical 
results. PRx, PAx and RAC perform similar in outcome association for both dichotomized outcomes, 
alive/dead and favourable/unfavourable, with RAC trending towards higher AUC values.  There were 
statistically higher mean values for the index, % time above threshold and hourly dose above threshold 
for each of PRx, PAx and RAC in those patients with poor outcomes.   
Conclusions: PRx, PAx and RAC appear similar in their associations with 6 to 12-month outcome in 
moderate/severe adult TBI, with RAC showing tendency to achieve stronger associations. Further work 
is required to determine the role for each of these cerebrovascular indices in monitoring of TBI patients.  
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Introduction: 
Various continuous indices for monitoring cerebrovascular reactivity exist.[2, 7, 20]  These indices are 
derived from the different cranial multi-modal monitoring (MMM) devices employed for the monitoring 
of critically ill patients.  In the traumatic brain injury (TBI) literature, the indices derived from invasive 
intra-cranial pressure (ICP) monitoring are the most widely described, with pressure reactivity index (PRx 
– the correlation between ICP and mean arterial pressure (MAP)) considered a  standard, and widely 
applied, index for monitory cerebrovascular reactivity in adult TBI.[1, 3, 6–9, 13, 16, 18, 20, 22] 
The literature supports a strong association between PRx and global patient outcome in adult TBI,[7, 18] 
with experimental literature validating it as a measure of cerebral autoregulation.[4, 19, 23]  However, 
two other ICP derived indices exist:  pulse amplitude index – PAx (correlation between pulse amplitude 
of ICP (AMP) and MAP),[2] and RAC (correlation (R) between AMP (A) and cerebral perfusion pressure 
(CPP)).[21] Both of these newer indices have also been validated as measures of cerebral autoregulation 
in experimental animal models.[19, 23]  However, it must be noted that all three of these ICP-derived 
indices have only been validated against the lower limit of autoregulation,[4, 19, 23]  with literature 
validating their ability to detect the upper limit currently unavailable. 
Some preliminary literature based on single-centre retrospective study supports the superiority of RAC 
in its association with 6-month global outcome, over both PRx and PAx, in adult TBI.[22]  The goal of this 
multi-center study, using the high resolution intensive care unit (ICU) cohort from the Collaborative 
European Neuro Trauma Effectiveness Research in TBI (CENTER-TBI) study,[15] was to determine which 
ICP index of cerebrovascular reactivity is superior in its association with 6 to 12-month global outcome 
in adult TBI, evaluating raw index values and derived parameters. 
 
Methods: 
Patient Population: 
All patients from the multi-center CENTER-TBI high resolution ICU cohort were included for this study.  
These patients were prospectively recruited during the periods of January 2015 to December 2017. A 
total of 21 centers in the European Union (EU) recruited patients for this cohort. All patients were 
admitted to ICU for their TBI during the course of the study, with high frequency digital signals recorded 
from their ICU monitors during the course of their ICU stay.  All patients suffered predominantly 
suffered from moderate to severe TBI (moderate = Glasgow Coma Score (GCS) 9 to 12, and severe = GCS 
of 8 or less).  A minority of patients suffered from non-severe TBI, with subsequent early deterioration 
leading to ICU admission for care and monitoring.  All patients in this cohort had invasive ICP monitoring 
conducted in accordance with the BTF guidelines.[5]   
 
Ethics: Data used in these analyses were collected as part of the CENTER-TBI study (IRAS No: 150943; 
REC 14/SC/1370).  The CENTER-TBI study (EC grant 602150) has been conducted in accordance with all 
relevant laws of the EU if directly applicable or of direct effect and all relevant laws of the country where 
the Recruiting sites were located, including but not limited to, the relevant privacy and data protection 
laws and regulations (the “Privacy Law”), the relevant laws and regulations on the use of human 
materials, and all relevant guidance relating to clinical studies from time to time in force including, but 
not limited to, the ICH Harmonised Tripartite Guideline for Good Clinical Practice (CPMP/ICH/135/95) 
(“ICH GCP”) and the World Medical Association Declaration of Helsinki entitled “Ethical Principles for 
Medical Research Involving Human Subjects”. Informed Consent by the patients and/or the legal 
representative/next of kin was obtained, accordingly to the local legislations, for all patients recruited in 
the Core Dataset of CENTER-TBI and documented in the e-CRF. 
Data Collection: 
As part of recruitment to the multi-center high resolution ICU cohort of CENTER-TBI,[15] all patients had 
demographics prospectively recorded.  Similarly, all patients had high frequency digital signals from ICU 
monitoring recorded throughout their ICU stay, with the goal of initiating recording within 24 hours of 
injury.  All digital ICU signals were further processed (see Signal Acquisition/Signal Processing). For the 
purpose of this study, the following admission demographic variables were collected:  age, sex and 
admission Glasgow Coma Scale (GCS – total and motor). Data was accessed on Sept 16th, 2018 via Opal 
database software.[10] 
 
Signal Acquisition: 
Arterial blood pressure (ABP) was obtained through either radial or femoral arterial lines connected to 
pressure transducers (Baxter Healthcare Corp. CardioVascular Group, Irvine, CA).  ICP was acquired via 
an intra-parenchymal strain gauge probe (Codman ICP MicroSensor; Codman & Shurtleff Inc., Raynham, 
MA), parenchymal fiber optic pressure sensor (Camino ICP Monitor,  Integra Life Sciences, Plainsboro, 
NJ, United States; https://www.integralife.com/) or external ventricular drain.  All signals were recorded 
using digital data transfer or digitized via an A/D converter (DT9801; Data Translation, Marlboro, MA), 
where appropriate, sampled at frequency of 100 Hertz (Hz) or higher, using the ICM+ software 
(Cambridge Enterprise Ltd, Cambridge, UK, http://icmplus.neurosurg.cam.ac.uk) or Moberg CNS 
Monitor (Moberg Research Inc, Ambler, PA, USA) or a combination of both.  Signal artifacts were 
removed using both manual and automated methods prior to further processing or analysis. 
Physiologic signals were recorded throughout the duration of ICP monitoring for the patients, with 
initiation of recording within 24 hours of the injury. For the patients undergoing decompressive 
craniectomy, there were 45 in this cohort. Seventeen patients had secondary decompressive 
craniectomies (ie. for refractory ICP), and thus had recordings both pre- and post-craniectomy.  The 
remaining 28 underwent primary craniectomies near the time of admission, and thus only had 
physiologic signals recorded for the periods after craniectomy. 
 
 
Signal Processing: 
Post-acquisition processing of the above signals was conducted using ICM+.  CPP was determined as CPP 
= MAP – ICP.  AMP was determined by calculating the fundamental Fourier amplitude of the ICP pulse 
waveforms over a 10 second window, updated every 10 seconds.  Ten second moving averages (updated 
every 10 seconds to avoid data overlap) were calculated for all recorded signals:  ICP, ABP (which 
produced MAP), AMP and CPP. This 10-second moving average filter is applied to the raw signals so as 
to decimate signal frequency into the range appropriate for vasogenic slow-wave evaluation (ie. 0.05 to 
0.005Hz).[11, 12] 
Continuous indices of cerebrovascular reactivity were derived via the moving correlation coefficient 
between 30 consecutive 10 second mean windows (ie. vasogenic slow-wave fluctuations) of the parent 
signals, updated every minute. PRx was derived via the correlation between slow-wave fluctuations (ie. 
0.05 to 0.005Hz) in ICP and MAP.[7, 11, 12] PAx was derived via the correlation between slow-wave 
fluctuations in AMP and MAP. RAC was derived via the correlation between slow-wave fluctuations in 
AMP and CPP. The focus on slow-wave frequency-range (ie. 0.05 to 0.005Hz) is conducted to evaluate 
the vasogenic responses in the cerebrovascular system, with this frequency range validated in the 
literature to provide the optimal discriminatory frequency for phase-shift between signals.[11, 12] 
PRx has been thoroughly described in the TBI literature, with numerous publications to date.[7, 16, 18, 
20, 22] PAx, has been sparingly described and has displayed potential superiority over PRx in patients 
with persistently low ICP throughout their ICU stay.[2, 22] RAC is a newly described index which provides 
some suggestion of stronger association with 6-month outcome, compared to PRx and PAx.[21, 22]  In 
general, these moving correlation coefficients between slow-wave fluctuations (ie. frequency range of 
0.05 to 0.005Hz)[11, 12] in a measure of pulsatile cerebral blood volume, such as ICP or AMP, and a 
driving pressure to blood flow, such as MAP or CPP, provide information regarding cerebrovascular 
reactivity, with all three having some validation in experimental models of arterial hypotension[4, 23] 
and/or intra-cranial hypertension[19] as measures of the lower limit of autoregulation.  These indices 
range from +1.0, which typically denotes severely impaired cerebral autoregulation, to -1.0, denoting 
intact autoregulation.[20]  Various critical thresholds associated with 6-month outcome for each index 
have been described in the clinical literature.[18, 22] 
Data was provided in minute-by-minute comma separated variable sheets for the entire duration of ICP 
recording for each patient. The median recording duration for the included patients was 136.0 hours 
(IQR: 90.2 to 182.3 hours). 
 
Data Processing: 
Grand mean values of all physiologic variables were calculated per patient.  In addition, the following 
post-ICM+ processing of this physiologic data occurred in R (R Core Team (2016). R: A language and 
environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL 
https://www.R-project.org/): 
 Cerebrovascular Reactivity Indices 
a. PRx – For each patient the % of time spent above the following clinically defined 
thresholds were calculated across the entire recording period:  0, +0.25, +0.35. In 
addition, mean hourly dose of PRx above each of these thresholds were calculated.  
 
b. PAx – For each patient the % of time spent above the following clinically defined 
thresholds were calculated across the entire recording period:  0, +0.25. In addition, 
mean hourly dose of PAx above each of these thresholds were calculated.  
 
c. RAC – For each patient the % of time spent above the following clinically defined 
thresholds were calculated across the entire recording period: -0.10, -0.05. In addition, 
mean hourly dose of RAC above each of these thresholds were calculated 
 
 
Statistics: 
All statistical analysis was conducted using R (R Core Team (2016). R: A language and environment for 
statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-
project.org/) and XLSTAT (Addinsoft, New York, NY; https://www.xlstat.com/en/) add-on package to 
Microsoft Excel (Microsoft Office 15, Version 16.0.7369.1323).  Normality of continuous variables was 
assessed via Shapiro-Wilks test.  For all testing described within, the alpha was set at 0.05 for 
significance.  
Despite GOSE being collected at both 6- and 12-months post-injury in this cohort of patients, there was 
missing data present in both categories of outcome. At the time point of data access for this study (Sept 
2018), imputed global outcomes were not available for this cohort, and are currently still to focus of a 
separate ongoing larger project on data imputation in CENTER-TBI, including the small number of high-
resolution patients and the larger non-high-resolution ICU cohorts. Thus, we combined GOSE scores 
from both 6 and 12 months in order to provide a “6 to 12 Month” GOSE.  For patients where GOSE was 
reported for both 6 and 12 months, the superior GOSE score was selected for analysis.  GOSE was then 
dichotomized into the following categories:  A. Alive (GOSE 2 to 8) vs. Dead (GOSE 1); and B. Favourable 
(GOSE 5 to 8) vs. Unfavourable (GOSE 4 or less).  Demographics and physiologic variables were 
compared between each dichotomized group, via t-test, Mann-U and chi-square testing where 
appropriate.   
Univariate logistic regression (ULR) was conducted, comparing each ICP cerebrovascular reactivity index 
variable (ie. mean index value, % time above threshold, and mean hourly dose above threshold) to both 
dichotomized outcomes, assessing superiority via AUC and Delong’s Test. Multi-variable models were  
not created in this study, as the focus was on univariate association with global outcome, in order to 
provide some validation for previous retrospective single center work on ICP-derived indices of 
cerebrovascular reactivity,[18, 22] and inform future planned multi-variable analysis. 
 
 
 
 
Results: 
Patient Population 
At the time of this analysis, a total of 204 patients from the CENTER-TBI high resolution ICU cohort had 
complete data sets, including: 6 to 12-month GOSE and high frequency physiologic signals containing at 
least ICP and ABP for ICP cerebrovascular index derivation. A total of 159 patients did not undergo 
decompressive craniectomy (DC).  The analysis was conducted in both the: total population (n=204) and 
the non-DC cohort (n=159), yielding similar results. The patient demographics for the entire cohort can 
be found summarized in Table 1. Mann-U and chi-square testing comparing various variables between 
the dichotomized outcome groups can be seen in Table 2 and 3.  Furthermore, the non-DC Patient 
cohort demographic and comparison between groups can be found in Appendix A of the supplementary 
materials.  
 
 *Table 1 here 
 
Comparison Between Dichotomized Outcome Groups 
Identical statistically significant differences between dichotomized outcome groups were noted in both 
the total population and the non-DC cohort (see Tables 3, 4 and Appendix A). In general, for the 
alive/dead outcome groups the following were statistically higher for the death group:  age, mean ICP, % 
time with ICP >20 mm Hg, % time with ICP >22 mm Hg, mean PRx, mean PAx, Mean RAC, mean % time 
above all index thresholds, and mean hourly dose above all index thresholds.   
Comparing favourable/unfavourable outcome groups, the statistically significant differences in variables 
were the same, with the exception for ICP based variables (mean ICP, % time with ICP > 20 mm Hg and > 
22 mm Hg), where these were not significantly different between groups. 
 
*Table 2 here 
 
*Table 3 here 
 
Univariate Logistic Regression Analysis 
Exploring just the ICP-based cerebrovascular reactivity index variables (ie. mean index value, % time 
above threshold and mean hourly dose above threshold) and their associations with dichotomize 
outcomes, identical results were seen for both the total population and the non-DC cohort.  Overall, the 
AUC’s for RAC based variables were higher in association with both alive/dead and 
favourable/unfavourable outcomes, as displayed in Table 4 (total population) and Appendix B of the 
supplementary materials (non-DC cohort).  However, comparing AUC’s, there was no statistically 
significant difference between PRx, PAx or RAC, when comparing similar variables (ie. mean value, % 
time above thresholds, hourly dose above threshold).  Thus, when assessing the core indices for 
outcome association, all three perform similarly, with RAC trending towards higher AUC’s. 
 
*Table 4 here 
 
Discussion: 
Using the high-resolution ICU cohort from the multi-centerCENTER-TBI study, we have performed a 
basic analysis of the outcome association the three ICP-derived cerebrovascular reactivity indices (PRx, 
PAx and RAC) in adult moderate/severe TBI.  Some interesting results deserve highlighting. 
Using both the total patient population and those without DC, all ICP derived indices performed similarly 
in their outcome association capacity for both 6 to 12-month dichotomized outcomes.  The variables 
derived from the indices and their known critical thresholds were all statistically significantly associated 
with both outcomes of interest.  RAC variables (ie. mean RAC, % time above threshold and mean hourly 
dose of RAC above threshold) overall displayed the highest AUC’s compared to those similar variables 
derived from PRx and PAx.  This however, was not statically different when comparing the AUC’s via 
Delong’s test. Thus, all core index variables performed similarly in outcome association, with a trend to 
higher AUC’s for RAC.  These results are in keeping with a previous large retrospective cohort analysis 
conducted to evaluate these three indices.[22] This lack of statistical significance between AUC’s may be 
a function of the relatively lower patient numbers, 204 for total population and 159 for non-DC cohort. 
Previous retrospective single centre comparisons were based on much larger cohorts (n=358).[7, 18, 22]  
Further, larger studies in patients with this type of high-resolution data is required to confirm credibility 
of our results.   Such larger multi-center studies are in the planning phase and not currently underway. 
However, when such studies are running it will be imperative to ensure that such complex high-
frequency physiologic data is curated in such a way that allows for sharing between centers globally.  It 
is only through such global initiatives, with standards in complex data collection/curation, that we will 
be able to produce large enough data sets to begin to definitively answer our questions related to 
metrics derived for high-frequency digital physiologic information.  
Comparing all three ICP derived indices of cerebrovascular reactivity, they all performed similarly in their 
association with both dichotomized outcomes.  This is in keeping with the only other study published 
evaluating all three indices in a single population.[22] As such, these findings were not a surprise, but 
confirmatory.  There was a trend, as mentioned, for AUC’s related to RAC to be higher.  This was also 
seen in the previous retrospective work.[22]  Thus, the next question may be why? All three indices have 
been validated as measures of the LLA in experimental models of arterial hypotension and/or intra-
cranial hypertension.[4, 19, 23]  Therefore, it isn’t surprising that they carry similar information 
regarding vascular reactivity, and thus perform similarly in clinical studies when assessing outcome 
prediction.  It is currently unknown if one index is superior to another in adult TBI. This would require 
much larger high-resolution patient populations, allowing various sub-population analyses to be 
performed, including but not limiting such sub-population analyses to those with: persistently low ICP, 
persistently high ICP, those with craniectomy (both primary and secondary), those with various types of 
intra-cranial pathology (ie. for example patients with contusions versus diffuse axonal injury, etc), 
variation in systemic fluid volume, and those with various types of ICU therapies on board (ie. sedatives, 
barbiturates, vasopressors, CSF drainage and hypothermia).  As such, at this time, it remains uncertain 
which index is superior in adult TBI. 
Finally, strictly evaluating the difference in mean values for variables between both dichotomized 
groups, it is clear that the cerebrovascular reactivity indices are far worse in those with poorer 
outcomes.  The mean values, % time above threshold and hourly dose above threshold were statistically 
higher for both those patients who died and had unfavourable outcomes. This is in contrast to the ICP 
variables (ie. % time with ICP > 20 mmHg, and % time with ICP > 22 mmHg), where the percentage of 
time above ICP threshold appears to only be significantly different (ie. higher) in those patients whom 
died, without any statistically significant differences for these ICP variables noted between favourable 
and unfavourable dichotomized outcome groups.  This highlights the known strong relationship 
between elevated ICP and death in TBI, with a weaker relation between ICP and long-term functional 
outcome.[5, 17, 18] The results from this study suggest that ICP-derived indices of cerebrovascular 
reactivity may be better predictors of functional outcome in adult TBI, compared to ICP values alone, 
emphasizing the potential importance of cerebrovascular reactivity monitoring in prognostication. 
However, the results of this study are preliminary, with these relationships requiring much further 
investigation.  
 
 
Limitations 
Despite the interesting and significant results, there are limitations which require addressing. 
First, despite having prospective multi-center data, the overall patient numbers for the total and non-DC 
cohorts are quite low.  This may impact the lack of statistical significance between AUC’s found when 
comparing PRx, PAx and RAC.  Thus, the results here are only preliminary and require further validation 
with larger high-resolution data sets gathered in a multi-center fashion. This power issue may be further 
reflected in the inability to display any statistically significant differences between admission GCS and 
the dichotomized outcome groups.  This particular finding was slightly surprising, given many other 
studies have documented worse admission GCS is associated with worse outcomes at 6 to 12 months 
post-TBI.[7, 14] This lack of difference is likely secondary to small patient numbers in the high-resolution 
ICU cohort, given the complexity in data curation for this cohort.  It is likely that when future analysis of 
the entire CENTER-TBI ICU cohort occurs, where there is no high-frequency physiology recorded, that 
GCS will display significant differences between dichotomized outcome groups. 
Second, treatment heterogeneity may have played a role in the signal values and associations seen.  
CENTER TBI was a prospective observational study, as such there exists a potential for intra-center and 
inter-center treatment heterogeneity. In particular, this study was an observational, not interventional, 
study, with the individual centers providing care a level consistent with BTF and local standards. As such, 
the heterogeneity in the extent and aggressiveness of care may have varied between centers.  The 
aggressiveness of care would impact the duration of monitoring data obtained, with more aggressive 
longer-term treatments leading to extended duration recordings.  As such, this treatment heterogeneity 
may not only impact the recorded physiologic signals, secondary to the therapies applied to ICP 
elevations, but also the duration of the recordings obtained, and thus potentially the associations with 
the dichotomized outcomes seen in our study.  With that said, all other large retrospective studies on 
cerebrovascular reactivity in the past have been subjected to such limitations of purely observational 
data, with their results in parallel to those found in the current study.[7, 18, 22] 
Third, the evaluation between systemic volume status, such as measured through central venous 
pressure or other methodologies, may prove interesting when compared to cerebrovascular reactivity 
monitoring.  There is the potential that fluid volume may correlate with vascular reactivity as measured 
through ICP derived indices, and requires investigation in future larger studies. 
Fourth, the population chosen was that with an outcome recorded at 6 to 12 months and high 
frequency digital signals, requiring all patients to have these particular set of variables for the models, 
hence the low patient numbers overall.  As such, we utilized the available non-imputed data and 
focused only on univariate models comparing various variables to dichotomized outcomes.  The focus of 
this manuscript was on univariate associations with global outcome, in order to provide validation for 
previous retrospective single center works on the topic,[22] while providing insight into these measures 
for future work on multi-variable prognostication that will be part of other works from the CENTER-TBI 
high resolution sub-study. The potential exists for these relationships to become insignificant when large 
multi-variable models are assessed.  At the time of this manuscript composition, there is currently a 
separate larger project underway for imputation of missing data components across all cohorts in 
CENTER-TBI (high-resolution and non-high-resolution), the results of which are not currently available 
and will be published in a separate piece.  Thus, at this time all we can comment on are the strength of 
univariate associations with outcome, though much further work on the topic is planned as data 
becomes available. 
Finally, it must be re-emphasized that the results here are preliminary only given the relatively small 
patient numbers and limitations outlined.  As such, they require much further investigation and 
validation. 
 
Conclusion: 
PRx, PAx and RAC appear similar in their associations with 6 to 12-month outcome in moderate/severe 
adult TBI, with RAC trending towards higher AUC values. Further work is required to determine the exact 
role for each of these cerebrovascular indices in monitoring TBI patients. 
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